These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7960409)

  • 1. The ocular tolerability of a new ophthalmic drug delivery system (NODS).
    Diestelhorst M; Krieglstein GK
    Int Ophthalmol; 1994; 18(1):1-4. PubMed ID: 7960409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dry Drops: a new preservative-free drug delivery system.
    Diestelhorst M; Grunthal S; Süverkrüp R
    Graefes Arch Clin Exp Ophthalmol; 1999 May; 237(5):394-8. PubMed ID: 10333106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term ocular toxicity and eye irritation tests following application of sufentanil in rabbits.
    Chen H; Chen Z; Xu Y
    Eye Sci; 2014 Dec; 29(4):193-7. PubMed ID: 26016069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a 0.9% sodium chloride ophthalmic solution on the ocular surface of symptomatic contact lens wearers.
    Barabino S; Rolando M; Camicione P; Chen W; Calabria G
    Can J Ophthalmol; 2005 Feb; 40(1):45-50. PubMed ID: 15825529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of topical azithromycin ophthalmic solution 1.0% in the treatment of contact lens-related dry eye.
    Nichols JJ; Bickle KM; Zink RC; Schiewe MD; Haque RM; Nichols KK
    Eye Contact Lens; 2012 Mar; 38(2):73-9. PubMed ID: 22157392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lifitegrast ophthalmic solution 5.0% for treatment of dry eye disease: results of the OPUS-1 phase 3 study.
    Sheppard JD; Torkildsen GL; Lonsdale JD; D'Ambrosio FA; McLaurin EB; Eiferman RA; Kennedy KS; Semba CP;
    Ophthalmology; 2014 Feb; 121(2):475-83. PubMed ID: 24289915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized phase I clinical study of cis-urocanic acid eye drops in healthy adult subjects.
    Jauhonen HM; Kari E; Pylkkänen L; Poutanen J; Laihia J; Kaarniranta K; Leino L
    Acta Ophthalmol; 2015 Jun; 93(4):368-76. PubMed ID: 25611308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic modeling of ophthalmic drug delivery to the anterior chamber by eye drops and contact lenses.
    Gause S; Hsu KH; Shafor C; Dixon P; Powell KC; Chauhan A
    Adv Colloid Interface Sci; 2016 Jul; 233():139-154. PubMed ID: 26318359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scintigraphic studies on the corneal residence of a New Ophthalmic Delivery System (NODS): rate of clearance of a soluble marker in relation to duration of pharmacological action of pilocarpine.
    Greaves JL; Wilson CG; Birmingham AT; Richardson MC; Bentley PH
    Br J Clin Pharmacol; 1992 Jun; 33(6):603-9. PubMed ID: 1389932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the efficacy and duration of action of topically applied proxymetacaine using a novel ophthalmic delivery system versus eye drops in healthy young volunteers.
    Lawrenson JG; Edgar DF; Gudgeon AC; Burns JM; Geraint M; Barnard NA
    Br J Ophthalmol; 1993 Nov; 77(11):713-5. PubMed ID: 8280685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerability and safety of two new preservative-free tear film substitutes.
    Dinslage S; Stoffel W; Diestelhorst M; Krieglstein GK
    Cornea; 2002 May; 21(4):352-5. PubMed ID: 11973381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An open-label evaluation of HP-Guar gellable lubricant eye drops for the improvement of dry eye signs and symptoms in a moderate dry eye adult population.
    Hartstein I; Khwarg S; Przydryga J
    Curr Med Res Opin; 2005 Feb; 21(2):255-60. PubMed ID: 15801996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy in patients with dry eye after treatment with a new lubricant eye drop formulation.
    Davitt WF; Bloomenstein M; Christensen M; Martin AE
    J Ocul Pharmacol Ther; 2010 Aug; 26(4):347-53. PubMed ID: 20653478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic absorption and adverse ocular and systemic effects after topical ophthalmic administration of 0.1% diclofenac to healthy cats.
    Hsu KK; Pinard CL; Johnson RJ; Allen DG; KuKanich BK; Nykamp SG
    Am J Vet Res; 2015 Mar; 76(3):253-65. PubMed ID: 25710762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contact lenses: promising devices for ocular drug delivery.
    Guzman-Aranguez A; Colligris B; Pintor J
    J Ocul Pharmacol Ther; 2013 Mar; 29(2):189-99. PubMed ID: 23215541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the analgesic efficacy and safety of nepafenac ophthalmic suspension compared with diclofenac ophthalmic solution for ocular pain and photophobia after excimer laser surgery: a phase II, randomized, double-masked trial.
    Colin J; Paquette B
    Clin Ther; 2006 Apr; 28(4):527-36. PubMed ID: 16750464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lifitegrast Ophthalmic Solution 5.0% versus Placebo for Treatment of Dry Eye Disease: Results of the Randomized Phase III OPUS-2 Study.
    Tauber J; Karpecki P; Latkany R; Luchs J; Martel J; Sall K; Raychaudhuri A; Smith V; Semba CP;
    Ophthalmology; 2015 Dec; 122(12):2423-31. PubMed ID: 26365210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of ocular and general safety following repeated dosing of dexamethasone phosphate delivered by transscleral iontophoresis in rabbits.
    Patane MA; Schubert W; Sanford T; Gee R; Burgos M; Isom WP; Ruiz-Perez B
    J Ocul Pharmacol Ther; 2013 Oct; 29(8):760-9. PubMed ID: 23844757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the fourth-generation fluoroquinolones gatifloxacin 0.3% and moxifloxacin 0.5% in terms of ocular tolerability.
    Donnenfeld E; Perry HD; Chruscicki DA; Bitterman A; Cohn S; Solomon R
    Curr Med Res Opin; 2004 Nov; 20(11):1753-8. PubMed ID: 15537475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanocarriers for treatment of ocular neovascularization in the back of the eye: new vehicles for ophthalmic drug delivery.
    Shen HH; Chan EC; Lee JH; Bee YS; Lin TW; Dusting GJ; Liu GS
    Nanomedicine (Lond); 2015; 10(13):2093-107. PubMed ID: 26096379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.